Bizmatics and OptimizeRx Collaborate to Help Patients Start and Stay on Therapies
NIAGARA FALLS, NY – Bizmatics Inc., a division of Harris and makers of PrognoCIS (“Bizmatics”), a leading provider of clinical and business productivity software and services, and OptimizeRx Corporation (“OptimizeRx”), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, have collaborated to increase support to healthcare providers (HCPs) and their patients at the point of care and beyond.
This partnership integrates the benefits of the OptimizeRx Therapy Initiation and Persistence Platform, which provides resources to HCPs, with our PrognoCIS Electronic Health Record (EHR) systems to help patients access and adhere to their treatments. Joining our best-in-class EHR workflow features will help HCPs save time and support transparent and productive conversations with their patients around potential barriers to staying on their medications, such as cost and access to these life-changing therapies, and other challenges.
HCPs often search for information about treatment plans and prescription information online. This partnership aims to save HCPs time by eliminating the need to leave the EHR workflow to find research to support their clinical decisions. Expanded treatment-specific information is accessible to HCPs at point-of-care, providing shortcuts to the guidance they need, precisely when they need it.
As always, we are committed to bringing the latest in technological advancements that ultimately enhance provider and patient experience. By partnering with OptimizeRx, we strive to provide efficient access to the best treatment options at the point of care, and potential cost savings for patients to help them start and stay on therapies.
“The ultimate benefits of developing an EHR software are not just the benefits to the providers but also to the patients. By extending prescription cost savings options to the patients, our clients can help their patients financially while demonstrating personalized patient care. It is a win-win for everyone involved,” said Marc Keller, EVP, Bizmatics.
“OptimizeRx is pleased to partner with Bizmatics to blend the capabilities of their PrognoCIS EHR products with the efficiencies that the OptimizeRx Therapy Initiation and Persistence Platform offers,” said OptimizeRx’s Chief Commercial Officer, Steve Silvestro. “Our platform touches providers and patients throughout the care journey, providing value in lowering out-of-pocket prescription drug costs, and providing resources in the prescribing journey, and in medication adherence.”
About Bizmatics: A Business Unit of Harris Computer
Bizmatics Inc., makers of the PrognoCIS EHR software, provides clinical and productivity software solutions to large and small Ambulatory and Occupation Medicine clinics. We offer single and multi-specialty databases. Our cloud-based application PrognoCIS is a fully integrated software consisting of EHR, Practice Management, Medical Billing, Patient Engagement Tools, Telemedicine and more!
OptimizeRx provides best-in-class health technology that enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. Connecting over 60% of U.S. healthcare providers and millions of their patients through the most intelligent technology platform embedded within a proprietary digital point-of-care network, OptimizeRx helps patients start and stay on their medications.
For more information, follow the Company on Twitter, LinkedIn or visit www.optimizerx.com
Important Cautions Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “anticipates”, “believes”, “estimates”, “expects”, “forecasts”, “intends”, “plans”, “projects”, “targets”, “designed”, “could”, “may”, “should”, “will” or other similar words and expressions are intended to identify these forward-looking statements. All statements that reflect the Company’s expectations, assumptions, projections, beliefs, or opinions about the future, other than statements of historical fact, are forward-looking statements, including, without limitation, statements relating to the Company’s growth, business plans, and future performance. These forward-looking statements are based on the Company’s current expectations and assumptions regarding the Company’s business, the economy, and other future conditions.
The Company disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise, except as required by applicable law. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition, and other risks summarized in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, its subsequent Quarterly Reports on Form 10-Q, and its other filings with the Securities and Exchange Commission.
Subscribe to Our Newsletter
The newsletter includes information about application updates, training/webinar schedules, and additional bonus content